Cardiovascular and diabetes outcomes among patients with obesity and type 2 diabetes after metabolic bariatric surgery or glucagon-like peptide 1 receptor agonist treatment
Compared with glucagon-like peptide 1 receptor agonist treatment, metabolic bariatric surgery is associated with superior metabolic outcomes and a lower risk of major cardiovascular events in patients with type 2 diabetes and obesity, but a higher risk of alcohol/substance abuse, self-harm, and fractures.
Authors
- Erik Stenberg (ORCID: https://orcid.org/0000-0001-9189-0093)
- Yang Cao (ORCID: https://orcid.org/0000-0003-1795-6474)
- Erik Näslund (ORCID: https://orcid.org/0000-0002-0166-6344)
- Johan Ottosson (ORCID: https://orcid.org/0000-0002-9243-2390)
- Magnus Sundbom (ORCID: https://orcid.org/0000-0002-6243-2859)
Institutions
- Uppsala University (SE)
- Örebro University (SE)
- Karolinska Institutet (SE)
Publication Details
- Journal
- British journal of surgery
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1093/bjs/znae221
- Citations
- 15
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 5.37